Literature DB >> 7044617

Heparin interferes with the radioenzymatic and homogeneous enzyme immunoassays for aminoglycosides.

D J Krogstad, G G Granich, P R Murray, M A Pfaller, R Valdes.   

Abstract

Heparin interferes with measurement of aminoglycosides in serum by biological, radioenzymatic, and homogeneous enzyme immunoassay techniques, but not with radioimmunoassay. At concentrations greater than or equal to 10(5) and greater than or equal to 3 X 10(6) USP units/L, respectively, it interferes with the radioenzymatic assay by inhibiting the gentamicin 3-acetyltransferase (EC 2.3.1.60) and kanamycin 6'-acetyltransferase (EC 2.3.1.55) enzymes used in the assay. It interferes with the homogeneous enzyme immunoassays for gentamicin and tobramycin (at concentrations greater than or equal to 10(5) and greater than or equal to 10(4) USP units/L, respectively), but not with the commercially available homogeneous enzyme immunoassays for other drugs. Heparin interference with the homogeneous enzyme immunoassay for aminoglycosides requires both the heparin polyanion and glucose-6-phosphate dehydrogenase (EC 1.1.1.49) bound to a cationic aminoglycoside. This interference can be reproduced with dextran sulfate (but not dextran), and does not occur with free enzyme (glucose-6-phosphate dehydrogenase) alone. We describe how heparin interferes with these two assays and demonstrate interference at heparin concentrations that may be present in intravenous infusions or in seriously underfilled blood-collection tubes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7044617

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  2 in total

Review 1.  Serum level monitoring of antibacterial drugs. A review.

Authors:  M Wenk; S Vozeh; F Follath
Journal:  Clin Pharmacokinet       Date:  1984 Nov-Dec       Impact factor: 6.447

2.  Analytical accuracy of determinations of aminoglycoside concentrations by enzyme multiplied immunoassay, fluorescence polarization immunoassay, and radioimmunoassay in the presence of heparin.

Authors:  M E O'Connell; K L Heim; C E Halstenson; G R Matzke
Journal:  J Clin Microbiol       Date:  1984-12       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.